Integra Lifesciences Holdings (IART) Current Taxes (2021 - 2026)

Integra Lifesciences Holdings (IART) reported Current Taxes of $3.2 million for Q1 2026, down 11.37% sequentially from $3.7 million in Q4 2025.

Integra Lifesciences Holdings (IART) Current Taxes (2021 - 2026) Analysis & Trends

Integra Lifesciences Holdings (IART) has 3 years of Current Taxes data on file, last reported at $3.2 million in Q1 2026.

For the quarter ending Q1 2026, Current Taxes changed N/A year-over-year to $3.2 million; the trailing twelve-month figure through Mar 2026 stood at $3.2 million (changed N/A YoY), and the FY2025 full-year result was $3.7 million, changed N/A from the prior year.
Current Taxes retreated to $3.2 million in Q1 2026, from $3.7 million in the prior quarter.
In the past five years, Current Taxes ranged from a high of $3.7 million in Q4 2025 to a low of $3.2 million in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	598.00 Mn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	476.00 Mn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	914.00 Mn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	-
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	-
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	-
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	231.81 Mn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	-
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	194.00 Mn
10	Integra Lifesciences Holdings	1.71 Bn	1.45 Bn	216.98 Mn	3.24 Mn

Download Data